KC Pharma
Private Company
Total funding raised: $47M
Overview
KC Pharma is a dominant, revenue-generating private label contract manufacturer specializing in OTC eye care products. It serves 26 of the top 30 US retailers, distributing to over 90,000 stores through a network of 200+ distribution centers from its 150,000-square-foot campus. The company leverages over 35 years of aseptic manufacturing expertise, a dedicated R&D team, and a strategic partnership with a world-class company to maintain its market leadership and first-to-market capabilities. Its business model is built on providing high-quality, affordable drug products and medical devices with a strong service orientation.
Technology Platform
Specialized aseptic fill manufacturing and formulation expertise for sterile ophthalmic solutions, supported by an FDA-inspected facility, state-of-the-art equipment, and an in-house R&D team focused on private label product development.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
KC Pharma competes in the private label contract manufacturing space, facing competition from other specialized CMOs and large generic pharmaceutical companies with manufacturing divisions. Its primary competitive advantages are its scale, dedicated focus on eye care, over 35 years of aseptic expertise, and its entrenched relationships with major North American retailers.